We are live on ! Find out more
LIAN

LianBio American Depositary Shares
LIAN

Delisted

LIAN was delisted on the 18th of March, 2024.

Back to rankings

29 hedge funds and large institutions have $377M invested in LianBio American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

221% more capital invested

Capital invested by funds: $118M → $377M (+$260M)

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

24% less funds holding

Funds holding: 38 → 29 (-9)

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

Holders
29
Holders Change
-9
Holders Change %
-23.68%
% of All Funds
0.42%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
8
Increased
11
Reduced
3
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$26M
2
AAA
Affinity Asset Advisors
New York
+$10.7M
3
BlackRock
BlackRock
New York
+$2M
4
AFM
Anson Funds Management
Texas
+$403K
5
TCM
Tybourne Capital Management
Hong Kong
+$328K

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.87M
2
Citigroup
Citigroup
New York
-$918K
3
Citadel Advisors
Citadel Advisors
Florida
-$757K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$573K
5
TD Asset Management
TD Asset Management
Ontario, Canada
-$532K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$257M – – –
TCM
2
Tang Capital Management
California
$41.9M +$26M +7,566,783 +420%
AAA
3
Affinity Asset Advisors
New York
$16.9M +$10.7M +3,107,337 +462%
Viking Global Investors
4
Viking Global Investors
Connecticut
$15.9M – – –
TCM
5
Tybourne Capital Management
Hong Kong
$15.2M +$328K +95,317 +3%
VVA
6
Vida Ventures Advisors
Massachusetts
$10.2M – – –
2L
7
22NW LP
Washington
$9.89M – – –
BlackRock
8
BlackRock
New York
$5.34M +$2M +580,528 +94%
Renaissance Technologies
9
Renaissance Technologies
New York
$1.55M +$218K +63,398 +22%
CC
10
Casdin Capital
New York
$923K – – –
AFM
11
Anson Funds Management
Texas
$524K +$403K +117,146 New
MA
12
MYDA Advisors
New York
$447K -$344K -100,000 -50%
Millennium Management
13
Millennium Management
New York
$188K -$531K -154,239 -79%
Invesco
14
Invesco
Georgia
$170K +$131K +38,039 New
OWP
15
Old Well Partners
North Carolina
$144K – – –
AWM
16
Axxcess Wealth Management
California
$121K +$36.2K +10,536 +64%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$112K +$19K +5,533 +28%
DLHL
18
Donald L. Hagan LLC
Florida
$92.1K +$19.3K +5,600 +37%
CSS
19
Cubist Systematic Strategies
Connecticut
$85.7K +$66K +19,179 New
Stifel Financial
20
Stifel Financial
Missouri
$82.7K +$1.6K +466 +3%
Osaic Holdings
21
Osaic Holdings
Arizona
$78.4K +$60.4K +17,555 New
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$65K -$573K -166,539 -92%
Bank of America
23
Bank of America
North Carolina
$60K +$5.42K +1,577 +13%
Two Sigma Investments
24
Two Sigma Investments
New York
$59.4K +$45.7K +13,291 New
Commonwealth Equity Services
25
Commonwealth Equity Services
Massachusetts
$48K – – –
1
2

LIAN Hedge Fund Activity: Q4 2023 in Review

29 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q4 2023, worth a combined $377M — up 221% from $118M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of LIAN and 8 opened new positions — a net loss of 8 holders — while 3 trimmed existing stakes and 11 added.

The largest buyer was Tang Capital Management, adding an estimated $26M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $3.87M sold.

  • 29 institutional investors held LianBio American Depositary Shares (LIAN) as of Q4 2023, down from 38 in Q3 2023.
  • Funds reported $377M of LianBio American Depositary Shares stock for Q4 2023, up 221% quarter-over-quarter.
  • 8 funds opened new LianBio American Depositary Shares positions in Q4 2023 and 16 closed out, a net change of -8 holders.
  • The largest LianBio American Depositary Shares buyer in Q4 2023 was Tang Capital Management, an estimated $26M added.
  • The largest LianBio American Depositary Shares seller in Q4 2023 was T. Rowe Price Associates, an estimated $3.87M sold.

Based on aggregated 13F filings for Q4 2023.